Crossignal Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Crossignal Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors (NCT06598007) | Crossignal Therapeutics, Inc. | 2024-09-20 |
Track Crossignal Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.